Beauty Farm Medical and Health Industry Inc. Fundamental Analysis
Beauty Farm Medical and Health Industry Inc. Fundamental Analysis
Beauty Farm Medical and Health Industry Inc. (2373.HK) shows moderate financial fundamentals with a PE ratio of 10.05, profit margin of 10.58%, and ROE of 33.37%. The company generates $3.2B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 57.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 2373.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak2373.HK struggles to generate sufficient returns from assets.
Valuation Score
Excellent2373.HK trades at attractive valuation levels.
Growth Score
Moderate2373.HK shows steady but slowing expansion.
Financial Health Score
Weak2373.HK carries high financial risk with limited liquidity.
Profitability Score
Moderate2373.HK maintains healthy but balanced margins.
Key Financial Metrics
Is 2373.HK Expensive or Cheap?
P/E Ratio
2373.HK trades at 10.05 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 2373.HK's PEG of 0.29 indicates potential undervaluation.
Price to Book
The market values Beauty Farm Medical and Health Industry Inc. at 3.18 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 5.49 times EBITDA. This is generally considered low.
How Well Does 2373.HK Make Money?
Net Profit Margin
For every $100 in sales, Beauty Farm Medical and Health Industry Inc. keeps $10.58 as profit after all expenses.
Operating Margin
Core operations generate 15.31 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $33.37 in profit for every $100 of shareholder equity.
ROA
Beauty Farm Medical and Health Industry Inc. generates $6.29 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Beauty Farm Medical and Health Industry Inc. generates strong operating cash flow of $1.07B, reflecting robust business health.
Free Cash Flow
Beauty Farm Medical and Health Industry Inc. generates strong free cash flow of $1.00B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $4.03 in free cash annually.
FCF Yield
2373.HK converts 27.42% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
10.05
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.29
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.18
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.15
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.27
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.98
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.33
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
0.21
vs 25 benchmark
How 2373.HK Stacks Against Its Sector Peers
| Metric | 2373.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 10.05 | 29.63 | Better (Cheaper) |
| ROE | 33.37% | 223.00% | Weak |
| Net Margin | 10.58% | -38669.00% (disorted) | Strong |
| Debt/Equity | 1.27 | 0.82 | Weak (High Leverage) |
| Current Ratio | 0.98 | 4.30 | Weak Liquidity |
| ROA | 6.29% | -379.00% (disorted) | Weak |
2373.HK outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Beauty Farm Medical and Health Industry Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation